Inventor
NIGEL ALAN SWAIN
Inventor
GB
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry11%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
12,552,799Triazolone compounds202612,528,8155-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer202612,492,174Morpholine-3-carboxamide derivatives as prostaglandin E2 receptor 4 (EP4) agonists for the treatment of gastrointestinal and pulmonary diseases202512,391,641Prostaglandin EP202512,344,621CGRP antagonist compounds202512,331,029Orexin 1 receptor antagonists202512,240,825Oxexin 1 receptor antagonists202512,234,227Pyrazole derivatives as H4 antagonist compounds202512,227,521CGRP antagonist compounds2025Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2025–2026Patents assigned to NXERA PHARMA UK LTD (9)· patent assignee history
2025Patents assigned to HEPTARES THERAPEUTICS LTD (1)· patent assignee history
2025Patents assigned to Nxera Pharma UK Limitied (1)· patent assignee history
2025–2026Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NXERA PHARMA UK LTD | 9 | 2025–2026 |
| HEPTARES THERAPEUTICS LTD | 1 | 2025 |
| Nxera Pharma UK Limitied | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 9 | 2025–2026 |